Aravive shares are trading lower after Cantor Fitzgerald downgraded the stock from Overweight to Neutral and lowered its price target from $18 to $0.25.
Portfolio Pulse from Benzinga Newsdesk
Aravive shares are trading lower after Cantor Fitzgerald downgraded the stock from Overweight to Neutral and lowered its price target from $18 to $0.25.
August 22, 2023 | 7:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aravive's stock was downgraded by Cantor Fitzgerald from Overweight to Neutral, with a significant reduction in price target from $18 to $0.25.
The downgrade by Cantor Fitzgerald, a major financial services firm, from Overweight to Neutral indicates a less optimistic outlook for the company. The drastic reduction in price target from $18 to $0.25 suggests a significant decrease in the perceived value of the company, which is likely to negatively impact the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100